MedTherapy Biotech
PrivateLast Round
Corporate Funding
Apr 5, 2024
Momentum
Top 25%
of companies Caplight tracks
Company Overview
MedTherapy Biotech operates in Healthcare & Life Sciences and is based in Quincy, Massachusetts. Its latest recorded funding round was a Corporate Funding round in April 2024.
MedTherapy Biotech is a biotechnology company that develops and manufactures cell, gene, and immunological therapies for cancer treatment.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Clinical Trials, Pharma Supply Chain, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting, Data as a Service
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
MedTherapy Biotech Comparables
Compare MedTherapy Biotech with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Artis BioSolutions | 84% | |
| ElevateBio | 81% | |
| Cellares | 81% |
For institutional investors. Book with your work email.
MedTherapy Biotech Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Corporate Funding | Apr 5, 2024 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
MedTherapy Biotech Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Massachusetts Biomedical Initiatives | Accelerator |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 27, 2026
Monthly visitors grew 238% MoM to 3.1K.
- Aug 26, 2025
Grew 22% QoQ from 51 to 62 employees.
For institutional investors. Book with your work email.
Recent news
Latest coverage and updates
- is_developingSep 7, 2026
MedTherapy Biotech is developing an integrated CAR-T cell therapy and contract development and manufacturing platform, with technology development capabilities in the United States and manufacturing infrastructure in India.
For institutional investors. Book with your work email.
MedTherapy Biotech Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about MedTherapy Biotech's valuation, stock price, and market status.
Is MedTherapy Biotech a public or private company?
MedTherapy Biotech is a private company.
What is the current stock price of MedTherapy Biotech?
MedTherapy Biotech is a private company, so its shares have no public market price. Caplight tracks MedTherapy Biotech's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is MedTherapy Biotech worth (valuation)?
Valuation information for MedTherapy Biotech is not publicly available.
Can I buy MedTherapy Biotech stock?
MedTherapy Biotech shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was MedTherapy Biotech's last funding round?
MedTherapy Biotech's most recent funding round was Corporate Funding on April 5, 2024.
Who are the main investors in MedTherapy Biotech?
Key investors in MedTherapy Biotech include Massachusetts Biomedical Initiatives.
Will MedTherapy Biotech IPO soon?
No public IPO plans have been announced for MedTherapy Biotech.
How can I track MedTherapy Biotech secondary market activity?
Caplight tracks bids, offers, and trades in MedTherapy Biotech's shares on secondary markets.